Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients.
Ridolfi L, Petrini M, Granato AM, Gentilcore G, Simeone E, Ascierto PA, Pancisi E, Ancarani V, Fiammenghi L, Guidoboni M, de Rosa F, Valmorri L, Scarpi E, Nicoletti SV, Baravelli S, Riccobon A, Ridolfi R.
Ridolfi L, et al. Among authors: granato am.
J Transl Med. 2013 May 31;11:135. doi: 10.1186/1479-5876-11-135.
J Transl Med. 2013.
PMID: 23725550
Free PMC article.